Financials Scandinavian Medical Solutions A/S
Equities
SMSMED
DK0061675006
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.22 DKK | -2.20% |
|
-5.76% | -16.17% |
Valuation
Fiscal Period: September | 2022 | 2023 |
---|---|---|
Capitalization 1 | 122.6 | 281.4 |
Enterprise Value (EV) 1 | 94.97 | 302 |
P/E ratio | 10.8 x | 23 x |
Yield | - | - |
Capitalization / Revenue | 1.11 x | 1.47 x |
EV / Revenue | 0.86 x | 1.58 x |
EV / EBITDA | 6.19 x | 14.3 x |
EV / FCF | -31,27,790 x | -62,70,081 x |
FCF Yield | -0% | -0% |
Price to Book | 1.97 x | 3.78 x |
Nbr of stocks (in thousands) | 27,250 | 27,317 |
Reference price 2 | 4.500 | 10.30 |
Announcement Date | 21/11/22 | 20/11/23 |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 41.95 | 71.64 | 110.5 | 191.2 |
EBITDA 1 | 5.989 | 10.9 | 15.35 | 21.08 |
EBIT 1 | 5.965 | 10.87 | 14.74 | 16.63 |
Operating Margin | 14.22% | 15.18% | 13.34% | 8.7% |
Earnings before Tax (EBT) 1 | 5.818 | 10.54 | 14.71 | 15.79 |
Net income 1 | 4.511 | 8.157 | 11.37 | 12.22 |
Net margin | 10.75% | 11.39% | 10.29% | 6.39% |
EPS | - | - | 0.4173 | 0.4478 |
Free Cash Flow | - | 2.328 | -30.36 | -48.17 |
FCF margin | - | 3.25% | -27.47% | -25.2% |
FCF Conversion (EBITDA) | - | 21.36% | - | - |
FCF Conversion (Net income) | - | 28.54% | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 09/12/21 | 09/12/21 | 21/11/22 | 20/11/23 |
Balance Sheet Analysis
Fiscal Period: September | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | - | - | - | 20.7 |
Net Cash position 1 | 10.6 | 25.4 | 27.7 | - |
Leverage (Debt/EBITDA) | - | - | - | 0.9812 x |
Free Cash Flow | - | 2.33 | -30.4 | -48.2 |
ROE (net income / shareholders' equity) | - | 56.3% | 26.4% | 17.9% |
ROA (Net income/ Total Assets) | - | 22% | 12.2% | 7.69% |
Assets 1 | - | 37.03 | 93.06 | 158.9 |
Book Value Per Share | - | - | 2.280 | 2.730 |
Cash Flow per Share | - | - | 1.020 | 0.2900 |
Capex | - | - | 13.8 | 40.8 |
Capex / Sales | - | - | 12.45% | 21.35% |
Announcement Date | 09/12/21 | 09/12/21 | 21/11/22 | 20/11/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-16.17% | 2.51Cr | |
+7.25% | 22TCr | |
+11.11% | 19TCr | |
+27.75% | 15TCr | |
+34.16% | 11TCr | |
+1.98% | 6.32TCr | |
+19.57% | 5.48TCr | |
+0.13% | 4.85TCr | |
-2.29% | 3.89TCr | |
+2.41% | 3.61TCr |
- Stock Market
- Equities
- SMSMED Stock
- Financials Scandinavian Medical Solutions A/S